Cancer Organoid

Ovarian Cancer Organoid

Tailored Tumor Recreation
Our ovarian cancer organoids meticulously mirror individual patient tumors, supporting the formulation of specific treatments.
Enhanced Disease Insight
These organoids serve as precise tools for exploring ovarian cancer dynamics and evaluating potential treatments, crucial for breakthroughs in care.
Optimized Drug Development
Leveraging our ovarian cancer organoids streamlines the evaluation of new therapeutic agents, cutting down on the time and expense involved in advancing clinical solutions.


Price	1784€+ Login to see price
Organism	Human
Product Type	Organoid
Tissue	Ovarian cancer tissue
Disease	Ovarian Cancer

Applications

Oncology

Small Molecule

Antibody

Cancer Vaccine

mRNA

Immune Cell

TME-CAF

Immuno Oncology

Macrophage

Regulatory T Cell

Tumor-Infiltrating Lymphocyte

Cytotoxic T Cell

Description

Advanced Ovarian Cancer Research with hOVC Organoids

Experience the next level of ovarian cancer research with our hOVC organoids. Utilizing sophisticated 3D cell culture techniques, these organoids replicate the intricate microenvironment of human ovarian cancer, capturing the diverse cellular makeup of the disease.
This advanced modeling enables more accurate simulation of tumor behavior, providing a critical tool for pioneering new treatments and understanding cancer’s complex dynamics.
Step into a new realm of precision oncology with our innovative organoids.

Ovarian cancer organoid

	H&E	CA125	HE(HE4)	PAX8	WT1
Cancer tissue
Cancer organoid

Our hOVC organoids are at the forefront of ovarian cancer research, precisely replicating the expression patterns of key markers such as CA125, HE4, PAX8, and WT1 found in patient tumors.
This high-fidelity modeling captures the complex pathology of ovarian cancer, enabling deeper insights into the disease mechanisms.
By accurately mimicking these molecular features, our organoids serve as a powerful tool for developing personalized therapies, promising a new era of treatment innovations that are as precise as they are effective.
Dive into the future of ovarian cancer treatment with our cutting-edge hOVC organoids and witness how we turn advanced research into life-saving solutions.

Drug Response

Our human ovarian cancer (hOVC) organoids provide unique insights into drug responses, enabling precision in therapeutic analysis. By differentiating how each organoid reacts to treatments, we can tailor cancer therapies to individual tumor profiles. This approach enhances the effectiveness of treatments, ensuring personalized care based on detailed, reliable data. Dive into the future of personalized medicine with our advanced hOVC organoids.